Arcutis Biotherapeutics (ARQT)'s 30-day implied volatility (IV30) was 61.5% at the close on October 20, 2026, up from 59.3% the day before, against a 52-week range of 28.0% to 76.1%. Its 20-day historical volatility was 65.3%.
Data as of October 20, 2026.